Bulletin
Investor Alert

Horizon Therapeutics PLC

NAS: HZNP

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 27, 2022, 5:17 p.m.

/zigman2/quotes/206690250/composite

$

94.84

Change

0.00 0.00%

Volume

Volume 164,431

Quotes are delayed by 20 min

/zigman2/quotes/206690250/composite

Previous close

$ 90.59

$ 94.84

Change

+4.25 +4.69%

Day low

Day high

$90.48

$94.86

Open

52 week low

52 week high

$82.51

$120.54

Open

Vikram Karnani

Vikram Karnani is President-International & Executive Vice President at Horizon Therapeutics Plc.

In his past career he was VP-Therapeutics & Cell Therapy Business at Fresenius Kabi USA LLC.

Mr. Karnani received an MBA from Kellogg School of Management, a graduate degree from Case Western Reserve University and an undergraduate degree from the University of Mumbai.

Transactions

Date Shares Transaction Value
02/22/2021 645   Disposition at $88.45 per share. 57,051
02/22/2021 7,713   Disposition at $87.08 per share. 671,649
02/17/2021 871   Derivative/Non-derivative trans. at $87.17 per share. 75,926
02/17/2021 1,965   Award at $0 per share. 0
01/22/2021 2,731   Disposition at $76.81 per share. 209,769
01/21/2021 2,173   Derivative/Non-derivative trans. at $77.43 per share. 168,256
01/21/2021 4,904   Derivative/Non-derivative trans. at $0 per share. 0
01/05/2021 49,906   Derivative/Non-derivative trans. at $73.28 per share. 3,657,112
01/05/2021 65,088   Award at $0 per share. 0
01/05/2021 47,337   Derivative/Non-derivative trans. at $0 per share. 0
08/03/2020 11,172   Derivative/Non-derivative trans. at $22.14 per share. 247,348
08/03/2020 25,600   Derivative/Non-derivative trans. at $9.23 per share. 236,288
06/01/2020 2,369   Disposition at $50.23 per share. 118,995
04/29/2020 15,683   Disposition at $35 per share. 548,905
04/28/2020 30,063   Disposition at $35.01 per share. 1,052,506
02/19/2020 6,649   Derivative/Non-derivative trans. at $36.06 per share. 239,763
02/19/2020 15,007   Award at $0 per share. 0
01/21/2020 2,173   Derivative/Non-derivative trans. at $38.25 per share. 83,118
01/21/2020 2,372   Derivative/Non-derivative trans. at $38.25 per share. 90,729
01/21/2020 4,904   Award at $0 per share. 0
01/06/2020 9,297   Disposition at $35.62 per share. 331,160
01/05/2020 24,225   Derivative/Non-derivative trans. at $36.1 per share. 874,523
01/05/2020 19,014   Award at $0 per share. 0
01/05/2020 35,242   Derivative/Non-derivative trans. at $0 per share. 0
07/01/2019 13,111   Disposition at $25.02 per share. 328,038
03/23/2019 4,209   Derivative/Non-derivative trans. at $26.84 per share. 112,970
03/23/2019 9,500   Derivative/Non-derivative trans. at $0 per share. 0
02/20/2019 8,622   Derivative/Non-derivative trans. at $21.54 per share. 185,718
02/20/2019 19,014   Award at $0 per share. 0
01/05/2019 7,962   Derivative/Non-derivative trans. at $20.39 per share. 162,346
01/05/2019 17,259   Derivative/Non-derivative trans. at $0 per share. 0
07/31/2018 1,663   Derivative/Non-derivative trans. at $17.63 per share. 29,319
07/31/2018 5,675   Derivative/Non-derivative trans. at $0 per share. 0
03/23/2018 4,209   Derivative/Non-derivative trans. at $13.86 per share. 58,337
03/23/2018 9,500   Derivative/Non-derivative trans. at $0 per share. 0
07/31/2017 2,662   Derivative/Non-derivative trans. at $11.98 per share. 31,891
07/31/2017 5,675   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Mr. Timothy P. Walbert
Chairman, President & Chief Executive Officer
Mr. Aaron L. Cox
Chief Financial Officer & Executive Vice President
Dr. Karin Rosen
Chief Scientific Officer
Dr. Elizabeth H. Z. Thompson
Executive Vice President-Research & Development
Dr. Jeffrey W. Sherman
Chief Medical Officer & Executive Vice President
Mr. Michael A. DesJardin
Executive VP-Technical Operations & Quality
Dr. Jeffrey D. Kent
Executive VP-Medical Affairs & Outcomes Research
Mr. Andy Pasternak
Chief Strategy Officer & Executive Vice President
Ms. Holly Copeland
Senior Director-Corporate Social Responsibility
Ms. Marilyn Vetter
Group Vice President-Market Access
Mr. Vikram Karnani
President-International & Executive Vice President
Mr. Miles W. McHugh
Chief Accounting Officer & Senior Vice President
Ms. Tina Ventura
Chief Investor Relations Officer & Senior VP
Ms. Jane Gonnerman
Chief of Staff & Group Vice President-Development
Ms. Irina P. Konstantinovsky
EVP, Chief Human Resources & Diversity Officer
Mr. David Caraher
Secretary
Mr. Sean M. Clayton
Executive Vice President & General Counsel
Dr. Susan Mahony
Independent Director
Mr. Michael G. Grey
Lead Independent Director
Dr. Jeff Himawan
Independent Director
Mr. William Francis Daniel
Independent Director
Ms. Pascale Witz
Independent Director
Dr. James Samuel Shannon
Independent Director
Mr. H. Thomas Watkins
Independent Director
Mr. Gino Santini
Independent Director
Link to MarketWatch's Slice.